Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01183689 · ClinicalTrials.gov registry record · NA
Study of Novel Approaches for Prevention
A NA study of Weight Gain, sponsored by Wake Forest University.
- Completed
- Registry status
- NA
- Development phase
- 599
- Enrollment target
- 2
- Study locations
NCT01183689: Completed NA study of Weight Gain, sponsored by Wake Forest University.
NCT01183689 is a NA study of Weight Gain that has completed, run by Wake Forest University. The registered enrollment target is 599 participants, above the 206-participant average among 38 other Weight Gain trials with a reported enrollment target (191% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01183689, a NA study of Weight Gain, has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- NA
- Development phase
- 599 participants
- Enrollment target
- 2
- Study locations
Study Summary
The Study of Novel Approaches for Prevention (SNAP) is randomized trial designed to test whether behavioral interventions based on self-regulation can prevent weight gain in young adults (18-35 years; body mass index (BMI) 21-30 kg/m2). Two different self-regulation interventions for weight gain prevention will be compared in this trial; one intervention will focus on making small, consistent, changes in eating and exercise behavior to prevent weight gain or reverse weight gain if it occurs, whereas the other will emphasize larger changes in eating and exercise that occur periodically, with a goal of producing weight loss and thereby providing a buffer against anticipated weight gains. The primary aim of the trial is to test whether the magnitude of weight gain from baseline across an average three-year follow-up differs across the three groups, with the hypotheses that weight gain will be greater in the Control group than in either intervention and greater in the Small Changes than Large Changes group. SNAP-E (Extension) will determine whether the effects of the intervention can be maintained over an additional 3 years (i.e. through a total of 6 years).
Primary Outcome
Mean weight change from baseline across an average planned follow-up of three years. These mean changes will be compared among the three arms of the trial.
Conditions Studied
Interventions
- BEHAVIORAL Small Behavior Changes
- BEHAVIORAL Large Behavior Changes
Study Locations (2)
North Carolina
- University of North Carolina - Chapel Hill
Rhode Island
- The Miriam Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 599 participants |
| Start Date | 2010-08 |
| Est. Completion | 2018-09-30 |
| Phase | NA |
What the finished NCT01183689 record still lists
NCT01183689 is an interventional study that assigns participants to a tested intervention. The registered 599 participants enrollment target is mid-sized for trials with a published cap, above the 206-participant average among 38 other Weight Gain trials with a reported enrollment target (191% higher).
The record links to 1 condition, with Weight Gain appearing as the primary indexed condition, and to 2 interventions - of which Small Behavior Changes is the first listed.
NCT01183689 reports a single indexed study location in North Carolina, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT01183689 about?
NCT01183689 is a clinical study titled "Study of Novel Approaches for Prevention". The Study of Novel Approaches for Prevention (SNAP) is randomized trial designed to test whether behavioral interventions based on self-regulation can prevent weight gain in young adults (18-35 years; body mass index (BMI) 21-30 kg/m2). Two different self-regulation interventions for weight gain pre...
What is the current status of trial NCT01183689?
This trial is currently completed. It is a NA study. The enrollment target is 599 participants. The study started on 2010-08. Estimated completion is 2018-09-30.
What conditions does trial NCT01183689 study?
This clinical trial studies the following conditions: Weight Gain.
What interventions are being tested in trial NCT01183689?
The interventions under investigation include: Small Behavior Changes (BEHAVIORAL), Large Behavior Changes (BEHAVIORAL).
Who is sponsoring clinical trial NCT01183689?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01183689 being conducted?
This trial has 2 study locations across North Carolina, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Gain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01183689's enrollment target sits among peer trials
599 3rd of 38 higher than 36 of 38 other Weight Gain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Weight Gain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
RECRUITING · NA
-
Testing Responses of Young Adults to Intervention Messages for Promoting Physical Activity Trial
RECRUITING · NA
-
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
RECRUITING · NA
-
Sleep and Metabolism
RECRUITING · NA
-
Exercise, Brain Activity, and Weight Maintenance
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06875973 · 599 participants · Phase 3
Pelacarsen Roll-over Extension Program
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia